Chan Benjamin K, Turner Paul E, Kim Samuel, Mojibian Hamid R, Elefteriades John A, Narayan Deepak
Department of Ecology and Evolutionary Biology, Yale University, New Haven, CT, USA.
Program in Microbiology, Yale School of Medicine, New Haven, CT, USA.
Evol Med Public Health. 2018 Mar 8;2018(1):60-66. doi: 10.1093/emph/eoy005. eCollection 2018.
Management of prosthetic vascular graft infections caused by can be a significant challenge to clinicians. These infections often do not resolve with antibiotic therapy alone due to antibiotic resistance/tolerance by bacteria, poor ability of antibiotics to permeate/reduce biofilms and/or other factors. Bacteriophage OMKO1 binding to efflux pump proteins in was consistent with an evolutionary trade-off: wildtype bacteria were killed by phage whereas evolution of phage-resistance led to increased antibiotic sensitivity. However, phage clinical-use has not been demonstrated. Here, we present a case report detailing therapeutic application of phage OMKO1 to treat a chronic infection of an aortic Dacron graft with associated aorto-cutaneous fistula. Following a single application of phage OMKO1 and ceftazidime, the infection appeared to resolve with no signs of recurrence.
由[具体病因未提及]引起的人工血管移植物感染的管理对临床医生来说可能是一项重大挑战。由于细菌对抗生素的耐药性/耐受性、抗生素渗透/减少生物膜的能力差和/或其他因素,这些感染通常仅用抗生素治疗无法解决。噬菌体OMKO1与[细菌名称未提及]中的外排泵蛋白结合符合一种进化权衡:野生型细菌被噬菌体杀死,而噬菌体抗性的进化导致抗生素敏感性增加。然而,噬菌体的临床应用尚未得到证实。在这里,我们报告一例详细病例,讲述了噬菌体OMKO1治疗主动脉涤纶移植物慢性[感染类型未提及]感染并伴有主动脉皮肤瘘的治疗应用。单次应用噬菌体OMKO1和头孢他啶后,感染似乎得到解决,没有复发迹象。